KINIKSA PHARMACEUTICALS INTL

Ticker: KNSA CUSIP: G52694109 Class: Common Stock

MARSHALL WACE, LLP's Holding History (CIK: 0001318757)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025

Shares 5,800 Value ($000) $239 Avg Close $40.11 Range $35.20 - $44.42

Q3 2025

Shares 61,316 Value ($000) $2,381 Avg Close $32.49 Range $26.27 - $39.00

Q2 2025

Shares 76,347 Value ($000) $2,113 Avg Close $25.46 Range $18.25 - $30.69

Q4 2024

Shares 86,762 Value ($000) $1,716 Avg Close $22.82 Range $19.47 - $28.15

Q3 2024

Shares 90,571 Value ($000) $2,263 Avg Close $24.36 Range $17.38 - $27.92

Period	Shares	Value ($000)	Average Close	Price Range
Q4 2025	5,800	$239	$40.11	$35.20 - $44.42
Q3 2025	61,316	$2,381	$32.49	$26.27 - $39.00
Q2 2025	76,347	$2,113	$25.46	$18.25 - $30.69
Q4 2024	86,762	$1,716	$22.82	$19.47 - $28.15
Q3 2024	90,571	$2,263	$24.36	$17.38 - $27.92